ALIYA FAYAZI: Open Payments
NPI 1265038723 · NORTH BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 37 payments from 10 companies in 2025. Trend: 2023 $158 · 2024 $579 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $137 |
| Exact Sciences Corporation | 5 | $108 |
| AstraZeneca Pharmaceuticals LP | 6 | $95 |
| Lilly USA, LLC | 4 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Novo Nordisk Inc | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $24 |
| PFIZER INC. | 1 | $18 |
| Impulse Dynamics (USA) Inc. | 1 | $11 |
Products named: TRELEGY ELLIPTA, FARXIGA, Cologuard Collection Kit, Kerendia, The Cologuard Plus Collection Kit, MOUNJARO, AMYVID, REXULTI.
Industry payments across NJ — which companies pay providers there.
